Sai Life Sciences
Mainboard₹14,823 / 27 Shares
Sai Life Sciences IPO Details
The Sai Life Sciences IPO price band is set between ₹522-549 per equity share, with a face value of ₹1 per share. The issue is managed by Kfin Technologies Limited, and the equity shares are proposed to be listed on the Mainboard.
The IPO date for subscription opens on 11 Dec, 2024 and closes on 13 Dec, 2024. Investors can check the allotment status on 16 Dec, 2024, while the listing date is tentatively scheduled for 18 Dec, 2024.
The total issue size is Total ₹3,042.62 Cr :#Fresh Issue : 17,304,189 shares, aggregating up to ₹950 Cr. Stay tuned for the latest Sai Life Sciences IPO review and GMP updates.
Sai Life Sciences IPO Review, Rating & Analysis
Sai Life Sciences IPO Review
NO REVIEWSai Life Sciences IPO Rating
Sai Life Sciences IPO Highlights
IPO Date
Dec 11, 2024 - Dec 13, 2024
Listing Date
18 Dec, 2024
Face Value
₹1 Per Equity Share
Price Band
₹522-549 per equity share
Lot Size
27 Shares
Fresh Issue
17,304,189 Shares
Offer for Sale
38,116,934 shares of ₹1
Listing At
BSE, NSE
Sai Life Sciences IPO Lot Size
The minimum market lot for Sai Life Sciences IPO is 27 shares with an application amount of ₹14,823. Retail investors can apply for up to 13 lots. The table below details the minimum and maximum investment limits for Retail and HNI investors.
| Application | Lots | Shares | Amount |
|---|---|---|---|
| Retail (Min) | 1 | 27 | ₹14,823 |
| Retail (Max) | 13 | 351 | ₹1,92,699 |
| S-HNI (Min) | 14 | 378 | ₹2,07,522 |
| S-HNI (Max) | 67 | 1809 | ₹9,93,141 |
| B-HNI (Min) | 68 | 1836 | ₹10,07,964 |
Sai Life Sciences IPO Timeline
Issue Price
₹522-549 per equity shareFace Value
₹1 Per Equity ShareListing at Group
BSE, NSERegistrar
Kfin Technologies LimitedLead Manager
Kotak Mahindra Capital Company LimitedJefferies India Private LimitedMorgan Stanley India Company Pvt LtdIifl Securities LtdIssue Size
Total ₹3,042.62 Cr :#Fresh Issue : 17,304,189 shares(aggregating up to ₹950 Cr) +
#OFS : 38,116,934 shares of ₹1(aggregating up to ₹2,092.62 Cr)
Sai Life Sciences IPO Financial Information
| Period Ended | Assets | Revenue | Profit After Tax | Net Worth | Reserves and Surplus | Total Borrowing |
|---|---|---|---|---|---|---|
| 31 Mar 24 | 2275.14 | 1494.27 | 82.81 | 974.34 | 953.99 | 710.16 |
| 31 Mar 23 | 2186.65 | 1245.11 | 9.99 | 887.29 | 867.43 | 699.23 |
| 31 Mar 22 | 2164.23 | 897.74 | 6.23 | 877.76 | 859.17 | 751.32 |
All values are in ₹ Cr.
Sai Life Sciences IPO Valuations
EPS Pre IPO
4.34EPS Post IPO
2.69PE Pre IPO
126.42PE Post IPO
203.82ROE
11.79%ROCE
15.96%Debt Equity
-RoNW
8.13%PAT Margin
5.65Price to Book Value
10.18Promoters & Share Holding
Promoter(s) Name
- Kanumuri Ranga Raju
- Krishnam Raju Kanumuri
- Kanumuri Mytrey
- Sai Quest Syn Private Limited
- Sunflower Partners
- Lily Partners
- Marigold Partners
- Tulip Partners
| Share Holding Pre Issue | Share Holding Post Issue |
|---|---|
| 40.48% | 35.10% |
About Company
Headquartered in January 1999, Sai Life Sciences Limited is a leading pharmaceutical firm specializing in the research and development and manufacturing of small-molecule new chemical entities (NCEs). It collaborates with global biotech firms and pharmaceutical giants and delivers customized solutions across the drug discovery and development continuum.
In FY 2024, Sai Life Sciences serviced over 280 pharmaceutical innovators, including 18 of the top 25 global pharmaceutical companies by revenue (2023). The company supported more than 230 clients in its key markets, such as the US, UK, Europe, and Japan alone in September 2024.
Sai Life Sciences is different for being an integrated CRDMO, offering end-to-end solutions fully combining discovery, development, and manufacturing. Its CRO services give a solid stage for discovery, and in its CDMO, all scaling is done reliably to take on commercial and developmental work.
Sai Life Sciences IPO Subscription Details
| As on | QIB | NII bNII sNII | Retail | Total |
|---|---|---|---|---|
| Shares Offered / Reserved | 11,084,225 | 8,313,168 5,542,113 2,771,056 | 19,397,392 | 38,794,785 |
Day 1 -11-12-24 05:00 PM | 2.62 x | 0.15 0.15 x 0.17 x | 0.18 x | 0.84 x |
Day 2 -12-12-24 05:00 PM | 3.32 x | 0.59 0.58 x 0.62 x | 0.42 x | 1.25 x |
Day 3 -13-12-24 05:00 PM | 30.93 x | 4.92 6.00 x 2.74 x | 1.37 x | 10.26 x |
Retail:0.86x
BHNI:0.66x
SHNI:2.68x times
Company Contact Details
Sai Life Sciences
Plot No. DS-7, IKP Knowledge Park, Turkapally Village, Shameerpet Mandal, Malkajgiri District, Hyderabad-500078Registrar Contact Details
Kfin Technologies Limited
Phone: 04067162222, 04079611000
Frequently Asked Questions about Sai Life Sciences IPO
When will Sai Life Sciences IPO open for subscription?
The Sai Life Sciences IPO opens on 11 Dec, 2024 and closes on 13 Dec, 2024.
What is the investors portion for Sai Life Sciences IPO?
The investors' portion for QIB is 30.93 x, NII is 6.00 x, and Retail is 1.37 x.
How to apply for Sai Life Sciences IPO?
You can apply for Sai Life Sciences IPO via ASBA online through your bank account. You can also apply via UPI through stock brokers like Zerodha, Upstox, or Paytm Money.
What is the issue size of Sai Life Sciences IPO?
The issue size of Sai Life Sciences IPO is approx ₹Total ₹3,042.62 Cr :#Fresh Issue : 17,304,189 shares(aggregating up to ₹950 Cr) +#OFS : 38,116,934 shares of ₹1(aggregating up to ₹2,092.62 Cr) crores.
What is the price band of Sai Life Sciences IPO?
The price band for Sai Life Sciences IPO is ₹522 to ₹549 per equity share.
What is the lot size of Sai Life Sciences IPO?
The minimum bid (lot size) for Sai Life Sciences IPO is N/A shares with an investment of approx ₹14,823 .
What is the allotment date of Sai Life Sciences IPO?
The allotment date for Sai Life Sciences IPO is 16 Dec, 2024.
What is the listing date of Sai Life Sciences IPO?
The listing date for Sai Life Sciences IPO is expected to be 18 Dec, 2024.
What is the GMP of Sai Life Sciences IPO?
The latest Grey Market Premium (GMP) for Sai Life Sciences IPO is being updated regularly on IPOROCK.
Parth D.
Founder & Lead Analyst
Parth D. is a software engineer and financial analyst who brings a quantitative edge to IPO tracking. With deep expertise in algorithmic trading and financial tool development, he builds the technology that powers IPORock's real-time data engines. He has been tracking the Indian market since 2018.